Celldex Therapeutics reported $-83.58M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
AbbVie USD 3.69B 1.68B Mar/2026
Agenus USD -10.11M 19.02M Mar/2025
Amgen USD 3.86B 1.28B Mar/2026
Bristol-Myers Squibb USD 4.24B 1.37B Mar/2026
Celldex Therapeutics USD -83.58M 2.76M Mar/2026
Glaxosmithkline GBP 2.77B 1.98B Mar/2026
Nektar Therapeutics USD -38.9M 7.09M Mar/2026
Northwest Biotherapeutics USD -13.41M 232K Sep/2023
Pfizer USD 6.01B 18M Jun/2026
Rigel Pharmaceuticals USD -4.17M 798K Sep/2023
Roche Holding CHF 13.43B 744M Jun/2026